Published in Int J Mol Sci on April 19, 2017
Inflammation and cancer. Nature (2002) 53.78
Cancer-related inflammation. Nature (2008) 34.21
Inflammation and cancer: back to Virchow? Lancet (2001) 27.40
ras oncogenes in human cancer: a review. Cancer Res (1989) 22.03
The global health burden of infection-associated cancers in the year 2002. Int J Cancer (2006) 13.57
Origin and physiological roles of inflammation. Nature (2008) 11.68
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet (2007) 11.06
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell (1988) 10.29
Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest (1993) 10.09
NF-kappaB: a key role in inflammatory diseases. J Clin Invest (2001) 9.66
Inflammation in prostate carcinogenesis. Nat Rev Cancer (2007) 9.08
Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. Cancer Cell (2007) 8.47
Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet (2007) 7.11
Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol (2009) 5.05
Inflammation, a key event in cancer development. Mol Cancer Res (2006) 5.03
Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med (2004) 4.47
Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. Nat Med (1999) 4.41
Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat Med (2009) 4.22
Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer Inst (2004) 4.07
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer (2013) 4.02
The global burden of cancer: priorities for prevention. Carcinogenesis (2009) 3.73
Crosstalk of reactive oxygen species and NF-κB signaling. Cell Res (2010) 3.71
HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clin Infect Dis (2007) 3.56
Cell proliferation in carcinogenesis. Science (1990) 3.43
Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis (2009) 3.40
ROS function in redox signaling and oxidative stress. Curr Biol (2014) 3.35
Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species. FEBS J (2008) 3.04
Dextran sodium sulphate colitis mouse model: traps and tricks. J Biomed Biotechnol (2012) 2.97
Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus. Gastroenterology (2002) 2.88
Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. Am J Physiol Gastrointest Liver Physiol (2005) 2.80
Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding. J Biol Chem (1999) 2.79
Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis. Blood (1990) 2.72
The carcinogenicity of outdoor air pollution. Lancet Oncol (2013) 2.71
Carcinoma arising in anorectal fistulas of Crohn's disease. Dis Colon Rectum (1998) 2.70
Chronic inflammation and cancer: the role of the mitochondria. Oncology (Williston Park) (2011) 2.65
Long-term ambient fine particulate matter air pollution and lung cancer in a large cohort of never-smokers. Am J Respir Crit Care Med (2011) 2.64
Chemical carcinogenesis: too many rodent carcinogens. Proc Natl Acad Sci U S A (1990) 2.60
Meta-analysis of measures of sexual activity and prostate cancer. Epidemiology (2002) 2.60
Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. Cancer Cell (2011) 2.56
A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat Rev Microbiol (2012) 2.56
Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: Physicians' Health Study. J Natl Cancer Inst (2009) 2.50
Recent advances in chemoprevention of cancer. Science (1997) 2.30
COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J (2009) 2.29
Mechanistic links between COPD and lung cancer. Nat Rev Cancer (2013) 2.28
A meta-analysis of asthma and risk of lung cancer (United States). Cancer Causes Control (2003) 2.24
Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm (2010) 2.18
Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res (1998) 2.15
Preventable exposures associated with human cancers. J Natl Cancer Inst (2011) 2.14
Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa. Gastroenterology (1995) 2.07
Role of the host in pathogenesis of Helicobacter-associated gastritis: H. felis infection of inbred and congenic mouse strains. Infect Immun (1996) 1.98
Host and microbial constituents influence Helicobacter pylori-induced cancer in a murine model of hypergastrinemia. Gastroenterology (2003) 1.96
FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin. Carcinogenesis (1993) 1.95
Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res (1998) 1.94
Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond. J Pharm Pharm Sci (2008) 1.94
gamma-tocopherol traps mutagenic electrophiles such as NO(X) and complements alpha-tocopherol: physiological implications. Proc Natl Acad Sci U S A (1997) 1.91
Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis. Hepatology (2005) 1.90
Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation. Int J Cardiol (2005) 1.89
Risk of malignancy in patients with celiac disease. Am J Med (2003) 1.85
Genomic landscape of carcinogen-induced and genetically induced mouse skin squamous cell carcinoma. Nat Med (2015) 1.80
Infiltration of neutrophils is required for acquisition of metastatic phenotype of benign murine fibrosarcoma cells: implication of inflammation-associated carcinogenesis and tumor progression. Am J Pathol (2003) 1.75
Effects of dimethylnitrosamine on induction of cholangiocarcinoma in Opisthorchis viverrini-infected Syrian golden hamsters. Cancer Res (1978) 1.75
Clinical Importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis. Clin Infect Dis (2011) 1.74
A cohort study of smoking, alcohol consumption, and dietary factors for pancreatic cancer (United States). Cancer Causes Control (1993) 1.74
The multitude and diversity of environmental carcinogens. Environ Res (2007) 1.73
Inflammation and Cancer. I. Rodent models of infectious gastrointestinal and liver cancer. Am J Physiol Gastrointest Liver Physiol (2004) 1.73
Biological agents. Volume 100 B. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum (2012) 1.73
Specific expression of hepatitis B surface antigen (HBsAg) in transgenic mice. Science (1985) 1.70
Inflammation, depression and dementia: are they connected? Neurochem Res (2007) 1.69
Progress in cancer chemoprevention: development of diet-derived chemopreventive agents. J Nutr (2000) 1.69
Dextran sulfate sodium-induced colitis-associated neoplasia: a promising model for the development of chemopreventive interventions. Acta Pharmacol Sin (2007) 1.68
Salmonella Manipulation of Host Signaling Pathways Provokes Cellular Transformation Associated with Gallbladder Carcinoma. Cell Host Microbe (2015) 1.63
Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer. Oncogene (2011) 1.56
Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis. Cancer Lett (2009) 1.54
Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention. Cancer Epidemiol Biomarkers Prev (1994) 1.52
Colony stimulating factors and myeloid cell biology in health and disease. Trends Immunol (2012) 1.52
Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus. Gastroenterology (2010) 1.51
Blockade of a chemokine, CCL2, reduces chronic colitis-associated carcinogenesis in mice. Cancer Res (2009) 1.51
Pulmonary tuberculosis increases the risk of lung cancer: a population-based cohort study. Cancer (2010) 1.51
Inflammation and cancer: role of nuclear factor-kappaB activation. Cancer Sci (2008) 1.49
Dextran sodium sulfate strongly promotes colorectal carcinogenesis in Apc(Min/+) mice: inflammatory stimuli by dextran sodium sulfate results in development of multiple colonic neoplasms. Int J Cancer (2006) 1.48
The association between papillary thyroid carcinoma and histologically proven Hashimoto's thyroiditis: a meta-analysis. Eur J Endocrinol (2013) 1.48
Gamma-tocopherol supplementation inhibits protein nitration and ascorbate oxidation in rats with inflammation. Free Radic Biol Med (2002) 1.46
Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats. Int J Cancer (1996) 1.43
The IkappaB kinase complex: master regulator of NF-kappaB signaling. Immunol Res (2008) 1.43
Human viral oncogenesis: a cancer hallmarks analysis. Cell Host Microbe (2014) 1.42
Role of chronic catheterization in the development of bladder cancer in patients with spinal cord injury. Urology (1999) 1.40
The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patients. J Hematol Oncol (2015) 1.40
Bartonella-host-cell interactions and vascular tumour formation. Nat Rev Microbiol (2005) 1.39
Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands. BMC Cancer (2005) 1.39
Rate of generation of oxidative stress-related damage and animal longevity. Free Radic Biol Med (2002) 1.37
Hepatocarcinogenesis due to chronic liver cell injury in hepatitis B virus transgenic mice. Cancer Res (1990) 1.34
Inhibitory effect of citrus nobiletin on phorbol ester-induced skin inflammation, oxidative stress, and tumor promotion in mice. Cancer Res (2000) 1.32
Mouse models for liver cancer. Mol Oncol (2013) 1.31
Microbial and viral pathogens in colorectal cancer. Lancet Oncol (2010) 1.30
An essential role of cytosolic phospholipase A2alpha in prostaglandin E2-mediated bone resorption associated with inflammation. J Exp Med (2003) 1.29
Emerging avenues linking inflammation and cancer. Free Radic Biol Med (2012) 1.28
A gamma-tocopherol-rich mixture of tocopherols inhibits colon inflammation and carcinogenesis in azoxymethane and dextran sulfate sodium-treated mice. Cancer Prev Res (Phila) (2009) 1.27
Angiosarcoma associated with foreign body material. A report of three cases. Cancer (1988) 1.24
Mechanism-based cancer prevention approaches: targets, examples, and the use of transgenic mice. J Natl Cancer Inst (1999) 1.23
Pyothorax-associated lymphoma: a lymphoma developing in chronic inflammation. Adv Anat Pathol (2005) 1.20